Clinical Updates
Gabapentin Now a Controlled Substance in Michigan
The Licensing and Regulatory Affairs Department in Michigan recently released changes to the state Controlled…
Drug Patents Expiring in 2019
The list below is comprised of prescription medications slated for drug patent expirations in 2019….
Launch of Generic Staxyn
The generic equivalent of Staxyn (Vardenafil) has recently launched. Staxyn is FDA-approved to treat erection…
Launch of Generic Levitra Tablets
The generic equivalent of Levitra (Vardenafil) has recently launched in the 2.5mg, 5mg, 10mg and…
Launch of Generic Androgel 1.62%
The generic equivalent of Androgel 1.62% (testosterone) has recently launched in the metered dose pump…
Launch of Generic Cialis Tablets
The generic equivalent of Cialis (Tadalafil) has recently launched in the 2.5mg, 5mg, 10mg and…
FDA Announces Manufacturer Recall of Valsartan Products
The medications, Valsartan and Valsartan-Hydrochlorothiazide, are being recalled by Prinston Pharmaceutical Inc. These medications may…
New Opioid Regulations for Tennessee
Starting July 1, 2018, several new regulations went into effect for the State of Tennessee….
Launch of Generic Suboxone
The generic equivalent of Suboxone (buprenorphine and naloxone) sublingual film (applied under the tongue) has…
Florida Controlled Substances Bill Takes Effect July 1, 2018
Florida has joined other states in enacting legislation designed to battle the nation’s Opioid Crisis….
